Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial
Author(s) -
Zaheer Abbas,
Seyede Zahra Ghodsi,
Robabeh Abedeni
Publication year - 2016
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.0603a04
Subject(s) - medicine , seborrheic dermatitis , itraconazole , placebo , dermatology , randomized controlled trial , quality of life (healthcare) , alternative medicine , pathology , antifungal , nursing
Few studies have examined the effect of seborrheic dermatitis (SD) and/or its consequent therapy on a patient's quality of life. Itraconazole has been suggested as an effective therapy for severe SD but its impact on Quality of Life (QoL) in these patients has never been studied before.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom